ABG Innovation Capital Partners III GP Ltd - NABRIVA THERAPEUTICS PLC ownership

Quarter-by-quarter ownership
ABG Innovation Capital Partners III GP Ltd ownership history of NABRIVA THERAPEUTICS PLC
ValueSharesWeighting
Q2 2022$8,000
-57.9%
45,8490.0%0.60%
-54.2%
Q1 2022$19,000
-29.6%
45,8490.0%1.30%
-16.8%
Q4 2021$27,000
-50.9%
45,8490.0%1.56%
-31.6%
Q3 2021$55,000
-11.3%
45,8490.0%2.28%
+998.6%
Q2 2021$62,000
-18.4%
45,8490.0%0.21%
+462.2%
Q1 2021$76,000
-31.5%
45,8490.0%0.04%
-43.1%
Q4 2020$111,00045,8490.06%
Other shareholders
NABRIVA THERAPEUTICS PLC shareholders Q3 2023
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 260,000$629,0000.12%
Values First Advisors, Inc. 42,308$102,0000.08%
FRAZIER MANAGEMENT LLC 425,650$1,030,0000.08%
ABG Innovation Capital Partners III GP Ltd 45,849$111,0000.06%
CCG WEALTH MANAGEMENT, LLC 10,480$25,0000.03%
GSA CAPITAL PARTNERS LLP 50,549$122,0000.02%
Clear Creek Financial Management, LLC 20,050$48,0000.01%
Granahan Investment Management 127,029$307,0000.01%
KESTRA PRIVATE WEALTH SERVICES, LLC 35,174$88,0000.01%
Virtu Financial LLC 22,060$53,0000.01%
View complete list of NABRIVA THERAPEUTICS PLC shareholders